GlycoMimetics
Yahoo Finance • 8 days ago
Crescent Biopharma Appoints Joshua Brumm as Chief Executive Officer and Expands Leadership Team to Advance Pipeline of Potentially Best-in-Class Oncology Therapeutics
Jonathan McNeill, M.D., Appointed President and Chief Operating Officer Ellie Im, M.D., Appointed Chief Medical Officer Additional Leadership Appointments: Rick Scalzo, MBA, as Chief Financial Officer, and Amy Reilly, as Chief Communicat... Full story
Yahoo Finance • last month
Crescent Biopharma to Present at the TD Cowen 45th Annual Health Care Conference
WALTHAM, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent”), a private biotechnology company dedicated to advancing novel precision engineered molecules targeting validated biology to advance care for patients... Full story
Yahoo Finance • 2 years ago
12 Best Multibagger Penny Stocks To Buy
In this article, we will take a look at the 12 best mulitbagger penny stocks to buy. To see more such companies, go directly to 5 Best Multibagger Penny Stocks To Buy. Apple Inc. (NASDAQ:AAPL). Amazon.com, Inc. (NASDAQ:AMZN). Microsoft Co... Full story
Yahoo Finance • 2 years ago
GlycoMimetics Announces Its Addition to the Russell Microcap® Index
ROCKVILLE, Md., June 26, 2023--(BUSINESS WIRE)--GlycoMimetics, Inc. (Nasdaq: GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced... Full story
Yahoo Finance • 2 years ago
We Think GlycoMimetics (NASDAQ:GLYC) Needs To Drive Business Growth Carefully
Just because a business does not make any money, does not mean that the stock will go down. For example, GlycoMimetics (NASDAQ:GLYC) shareholders have done very well over the last year, with the share price soaring by 203%. But while the s... Full story
Yahoo Finance • 2 years ago
GlycoMimetics to Report Third Quarter Financial Results on November 9, 2022
ROCKVILLE, Md., November 02, 2022--(BUSINESS WIRE)--GlycoMimetics, Inc. (Nasdaq: GLYC), today announced that it will host a conference call and webcast to report third quarter financial results on Wednesday, November 9, 2022, at 8:30 a.m.... Full story
Yahoo Finance • 3 years ago
GlycoMimetics to Report Second Quarter Financial Results on August 3, 2022
ROCKVILLE, Md., July 27, 2022--(BUSINESS WIRE)--GlycoMimetics, Inc. (Nasdaq: GLYC), today announced that it will host a conference call and webcast to report second quarter financial results on Wednesday, August 3, 2022, at 8:30 a.m. ET.... Full story
